Evidence map›Paper›PMID 41235810›Full record

SynthesisAlimentary pharmacology & therapeutics2026

Review Article: Extending the Frontiers of Intestinal Ultrasound Knowledge, Performance and Expansion.

Cathy Lu, Bram Verstockt, Michael W Winter, Britt Christensen, Dan Carter, Floris de Voogd, Michael Dolinger, Thomas Goodsall, Maureen O'Brien, Ryan Rosentreter and 3 more

Abstract readSystematic Review
In one paragraph

Synthesis in Alimentary pharmacology & therapeutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Cathy LuDivision of Gastroenterology and Hepatology, Department of Medicine, University of Calgary, Calgary, Canada.
Bram VerstocktDepartment of Gastroenterology and Hepatology, KU Leuven, University Hospitals Leuven, Leuven, Belgium.
Michael W WinterSection of Gastroenterology and Hepatology, Department of Medicine, Dartmouth-Hitchcock Medical Center, Lebanon, Pennsylvania, USA.
Britt ChristensenDepartment of Gastroenterology, Royal Melbourne Hospital, Melbourne, Australia.
Dan CarterGastroenterology Institute, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel.
Floris de VoogdDepartment of Gastroenterology and Hepatology, Amsterdam UMC, Location AMC, Amsterdam, the Netherlands.
Michael DolingerDivision of Pediatric Gastroenterology, Department of Pediatrics, NYU Grossman School of Medicine, New York, New York, USA.
Thomas GoodsallDepartment of Gastroenterology, John Hunter Hospital, Newcastle, New South Wales, Australia.
Maureen O'BrienDivision of Gastroenterology and Hepatology, Department of Medicine, University of Calgary, Calgary, Canada.
Ryan RosentreterDivision of Gastroenterology and Hepatology, Department of Medicine, University of Calgary, Calgary, Canada.
International Bowel Ultrasound (IBUS) Group
Mariangela AlloccaGastroenterology and Endoscopy, IRCCS Hospital San Raffaele, University Vita-Salute San Raffaele, Milan, Italy.
Rune WilkensDigestive Disease Center, Copenhagen University Hospital-Bispebjerg, Copenhagen, Denmark.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIntestinal ultrasonography (IUS) is increasingly utilised for diagnosing and monitoring IBD. Despite its cost-effectiveness, patient tolerance and suitability for serial bedside assessments, broad adoption has been limited by knowledge gaps in evidence, training and standardisation.

aimsTo summarise key knowledge gaps in the assessment of luminal disease activity, postoperative recurrence, complications, pouch-related disorders and the use of IUS in paediatrics, contrast enhancement, elastography, as well as education, training and future applications involving artificial intelligence.

methodsWe conducted a systematic umbrella review, following PRISMA guidelines, to map the current landscape of high-quality evidence and identify gaps in IUS research relevant to IBD. We searched MEDLINE from inception to February 2025 for systematic reviews, meta-analyses and consensus statements. We extracted data from eligible studies on design, outcomes and identified research gaps. Gaps were categorised by insufficient information, bias, inconsistency or lack of relevant data.

resultsSixty of 507 studies met inclusion criteria. Key gaps included lack of validated and standardised IUS activity indices for Crohn's disease and ulcerative colitis, limited evidence for IUS in post-operative recurrence, paediatric populations and perianal or pouch disease. Data on the use of contrast-enhanced ultrasound and elastography were sparse. Small sample sizes, heterogeneous designs and inadequate follow-up limited most studies. Training, competency assessment and integration of artificial intelligence remain underexplored.

conclusionsSizable gaps persist in the evidence base for IUS in IBD. Addressing these gaps through robust, multicentre studies and consensus-driven frameworks is essential to optimise the clinical and research utility of IUS in IBD management.

Indexed as

Inflammatory Bowel DiseasesIntestinesHumansUltrasonography

Identifiers

PMID41235810
PMCPMC12690238

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.